Publication | Open Access

A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies

Hematological MalignancyOncologyMarrow TransplantationTransplantationContinual Reassessment MethodMalignant Blood DisorderStem Cell TransplantationHematologyPharmacotherapyCell TransplantationMelphalan ConditioningImmunotherapyMedicineRadiation OncologyHealth Sciences